Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
CGrKnsTUg7JKwKce